Fed. Circ. Backs J&J Unit's Win In Glucose Test Strip IP Suit
The Federal Circuit affirmed Friday that a Johnson & Johnson subsidiary's blood-glucose test trips did not infringe two patents owned by a medical device maker, siding with a lower court that said the...To view the full article, register now.
Already a subscriber? Click here to view full article